Records containing: Melanoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-07-16
In Vivo Real-time Detection of Circulating Melanoma Cells
CLINICAL_TRIALS study record update · 2025-07-14
Pilot Evaluation of Focused Ultrasound Ablation and Focused Ultrasound Ablation Plus PD-1 Antibody Blockade in Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2025-07-11
A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (BMS-936558) Monotherapy or in Combination With Ipilimumab in Patients With Advanced (Unresectable or Metastatic) Melanoma and in Patients With Adjuvant Nivolumab Therapy
CLINICAL_TRIALS study record update · 2025-07-10
Phase Ib Study of a Monoclonal Antibody to OX40 (MEDI0562) Administered Prior to Surgical Resection in Patients With Head and Neck Squamous Cell Carcinoma or Melanoma
CLINICAL_TRIALS study record update · 2025-07-10
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-07-10
Radiation Therapy, Plasma Exchange, and Immunotherapy in Melanoma
CLINICAL_TRIALS study record update · 2025-07-09
Iron With Standard of Care Immunotherapy in Melanoma
CLINICAL_TRIALS study record update · 2025-07-08
LIMIT Melanoma: (Lysosomal Inhibition + Melanoma ImmunoTherapy) A Phase 1/2 Open Label Trial of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Patients With Advanced Melanoma
CLINICAL_TRIALS study record update · 2025-07-04
A Multicenter, Two Part Open-Label, Phase 1B Clinical Study of CMP-001 Administered Either in Combination With Pembrolizumab or as a Monotherapy in Subjects With Advanced Melanoma
CLINICAL_TRIALS study record update · 2025-07-04
A Phase 1a/1b Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of RO7198457 as a Single Agent and in Combination With Atezolizumab in Patients With Locally Advanced or Metastatic Tumors
CLINICAL_TRIALS study record update · 2025-07-02
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
CLINICAL_TRIALS study record update · 2025-07-01
Q-SAM (Using QPOP to Predict Treatment for Sarcomas and Melanomas)
CLINICAL_TRIALS study record update · 2025-07-01
A Phase 1 Study to Assess the Safety and Efficacy of LYL845 in Adults With Relapsed and/or Refractory Metastatic or Locally Advanced Melanoma and Selected Solid Tumor Malignancies
CLINICAL_TRIALS study record update · 2025-06-29
Improving Symptom Management for Survivors of Young Adult Cancer
CLINICAL_TRIALS study record update · 2025-06-29
Mature Dendritic Cell Vaccination Against gp100 in Patients With Advanced Melanoma
CLINICAL_TRIALS study record update · 2025-06-27
A Phase II Double-Blind Trial of Sulforaphane for Therapeutic Prevention of Melanoma in Patients With Multiple Atypical Nevi and a Prior History of Melanoma
CLINICAL_TRIALS study record update · 2025-06-26
Clinical Study to Evaluate the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocyte (CT-SP) in Patients With Refractory Melanoma Who Failed to Immune Checkpoint Inhibitors
CLINICAL_TRIALS study record update · 2025-06-22
Education for Prevention of Melanoma in Hispanic Populations
CLINICAL_TRIALS study record update · 2025-06-19
A Phase 1/2 Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced Cancers
CLINICAL_TRIALS study record update · 2025-06-15
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
CLINICAL_TRIALS study record update · 2025-06-13
A Phase I, Open-label, Dose Escalation Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands
CLINICAL_TRIALS study record update · 2025-06-08
A Phase I, Open Label, Single Center and Dose Escalation Study Investigating Tolerance and Pharmacokinetics of Single and Multiple Doses of Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Injection in Patients With Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2025-06-06
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy of BA1302 in Patients With Advanced Solid Malignancies
CLINICAL_TRIALS study record update · 2025-06-05
Randomized Phase III Trial of Standard Immunotherapy (IO) by Checkpoint Inhibitors, Versus Reduced Dose Intensity of IO in Patients With Locally Advanced or Metastatic Cancer in Response After 6 Months of Standard IO
CLINICAL_TRIALS study record update · 2025-05-31
ClinicalTrials.gov study NCT03593499